Fibronectin-1 expression is increased in aggressive thyroid cancer and favors the migration and invasion of cancer cells.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Molecular and Cellular Endocrinology

• Publication date

  2016-08-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.mce.2016.05.007PMID 27173027
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer : The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer

  2017cited by this paper
• Emerging strategies for managing differentiated thyroid cancers refractory to radioiodine

  2016cited by this paper
• Somatic amplifications and deletions in genome of papillary thyroid carcinomas

  2015cited by this paper
• Reduced expression of THRβ in papillary thyroid carcinomas: relationship with BRAF mutation, aggressiveness and miR expression

  2015cited by this paper
• Database and Registry Research in Thyroid Cancer: Striving for a New and Improved National Thyroid Cancer Database

  2015cited by this paper
• PDE5 expression in human thyroid tumors and effects of PDE5 inhibitors on growth and migration of cancer cells

  2015cited by this paper
• Induction of fibronectin by HER2 overexpression triggers adhesion and invasion of breast cancer cells.

  2015cited by this paper
• Targeted therapies in advanced differentiated thyroid cancer.

  2015cited by this paper
• Flavonoid Fraction of Citrus Reticulata Juice Reduces Proliferation and Migration of Anaplastic Thyroid Carcinoma Cells

  2015cited by this paper
• Advanced radioiodine-refractory differentiated thyroid cancer: the sodium iodide symporter and other emerging therapeutic targets.

  2014cited by this paper
• Fibronectin promotes migration and invasion of ovarian cancer cells through up‐regulation of FAK–PI3K/Akt pathway

  2014cited by this paper
• The Epidemic of Thyroid Cancer in the United States: The Role of Endocrinologists and Ultrasounds

  2014cited by this paper
• Immunohistochemical evaluation of midkine and nuclear factor-kappa B as diagnostic biomarkers for papillary thyroid cancer and synchronous metastasis.

  2014cited by this paper
• Molecular Pathways: Linking Tumor Microenvironment to Epithelial–Mesenchymal Transition in Metastasis

  2014cited by this paper
• Cooperation of histone deacetylase inhibitors SAHA and valproic acid in promoting sodium/iodide symporter expression and function in rat Leydig testicular carcinoma cells

  2014cited by this paper
• Molecular pathogenesis and mechanisms of thyroid cancer

  2013cited by this paper
• The Role of Epithelial Mesenchymal Transition Markers in Thyroid Carcinoma Progression

  2013cited by this paper
• Targeting histone deacetylase in thyroid cancer

  2013cited by this paper
• The PARP inhibitor PJ34 modifies proliferation, NIS expression and epigenetic marks in thyroid cancer cell lines.

  2013cited by this paper
• Antioxidant and antigrowth action of peracetylated oleuropein in thyroid cancer cells.

  2013cited by this paper
• (V600E)BRAF promotes invasiveness of thyroid cancer cells by decreasing E-cadherin expression through a Snail-dependent mechanism.

  2013cited by this paper
• Methylation levels of sodium–iodide symporter (NIS) promoter in benign and malignant thyroid tumors with reduced NIS expression

  2013cited by this paper
• Extracellular matrix protein fibronectin induces matrix metalloproteinases in human prostate adenocarcinoma cells PC-3

  2013cited by this paper
• Molecular differences between human thyroid follicular adenoma and carcinoma revealed by analysis of a murine model of thyroid cancer.

  2013cited by this paper
• Sunitinib Exerts Only Limited Effects on the Proliferation and Differentiation of Anaplastic Thyroid Cancer Cells

  2012cited by this paper
• The sodium iodide symporter (NIS): regulation and approaches to targeting for cancer therapeutics.

  2012cited by this paper
• FN1, GALE, MET, and QPCT overexpression in papillary thyroid carcinoma: Molecular analysis using frozen tissue and routine fine‐needle aspiration biopsy samples

  2011cited by this paper
• BRAF(V600E) and microenvironment in thyroid cancer: a functional link to drive cancer progression.

  2011cited by this paper
• Progression of BRAF-induced thyroid cancer is associated with epithelial-mesenchymal transition requiring concomitant MAP kinase and TGFβ signaling

  2011cited by this paper
• The p65 subunit of NF-κB and PARP1 assist Snail1 in activating fibronectin transcription

  2011cited by this paper
• Epigenetics of thyroid cancer and novel therapeutic targets.

  2011cited by this paper
• The BRAFT1799A mutation confers sensitivity of thyroid cancer cells to the BRAFV600E inhibitor PLX4032 (RG7204).

  2011cited by this paper
• The BRAF V600E Oncogene Induces Transforming Growth Factor β Secretion Leading to Sodium Iodide Symporter Repression and Increased Malignancy in Thyroid Cancer

  2009cited by this paper
• Basal nitric oxide release attenuates cell migration of HeLa and endothelial cells.

  2009cited by this paper
• Role of B-Raf(V600E) in differentiated thyroid cancer and preclinical validation of compounds against B-Raf(V600E).

  2009cited by this paper
• Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer

  2009cited by this paper
• The BRAFV600E oncogene induces transforming growth factor beta secretion leading to sodium iodide symporter repression and increased malignancy in thyroid cancer.

  2009cited by this paper
• 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer

  2009cited by this paper
• Clinical implications of BRAF mutation in thyroid carcinoma.

  2008cited by this paper
• High periostin expression correlates with aggressiveness in papillary thyroid carcinomas.

  2008cited by this paper
• Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer cell lines reveals cross-contamination resulting in cell line redundancy and misidentification.

  2008cited by this paper
• Molecular pathology of thyroid cancer: diagnostic and clinical implications.

  2008cited by this paper
• Defects in iodide metabolism in thyroid cancer and implications for the follow-up and treatment of patients

  2007cited by this paper
• BRAF mutations in papillary thyroid carcinomas inhibit genes involved in iodine metabolism.

  2007cited by this paper
• Comparative genomic hybridization, BRAF, RAS, RET, and oligo-array analysis in aneuploid papillary thyroid carcinomas.

  2007cited by this paper
• A multi-gene approach to differentiate papillary thyroid carcinoma from benign lesions: gene selection using support vector machines with bootstrapping

  2007cited by this paper
• Tumorigenesis and Neoplastic Progression Snail Family Transcription Factors Are Implicated in Thyroid Carcinogenesis

  2007cited by this paper
• Gene expression and functional evidence of epithelial-to-mesenchymal transition in papillary thyroid carcinoma invasion

  2007cited by this paper
• Meta-analysis and meta-review of thyroid cancer gene expression profiling studies identifies important diagnostic biomarkers.

  2006cited by this paper
• Endothelial nitric oxide synthase is segregated from caveolin-1 and localizes to the leading edge of migrating cells.

  2006cited by this paper
• Molecular Markers for Discrimination of Benign and Malignant Follicular Thyroid Tumors

  2006cited by this paper
• Complex networks orchestrate epithelial–mesenchymal transitions

  2006cited by this paper
• Molecular requirements for epithelial-mesenchymal transition during tumor progression.

  2005cited by this paper
• Galectin-3, fibronectin-1, CITED-1, HBME1 and cytokeratin-19 immunohistochemistry is useful for the differential diagnosis of thyroid tumors

  2005cited by this paper
• 1alpha,25-Dihydroxyvitamin D3 targets PTEN-dependent fibronectin expression to restore thyroid cancer cell adhesiveness.

  2005cited by this paper
• Gene expression in papillary thyroid carcinoma reveals highly consistent profiles

  2001cited by this paper
• Expression pattern of the pendrin and sodium/iodide symporter genes in human thyroid carcinoma cell lines and human thyroid tumors.

  2001cited by this paper
• Sodium-iodide symporter (NIS) gene expression in lymph-node metastases of papillary thyroid carcinomas.

  2000cited by this paper
• Papillary thyroid carcinomas

  1982cited by this paper

• IER3 Promotes Malignant Progression of Colorectal Cancer Through the NF‐κB Pathway

  2026cites this paper
• Exploring Molecular Signature and Prognostic Biomarkers in Ovarian Cancer: Insights From Late-Stage, Recurrent, and Metastatic Tumors.

  2026cites this paper
• Integrative multi-omics refines the molecular subtypes of thyroid cancers and enhances cancer-progression prediction: a retrospective cohort study.

  2026cites this paper
• Comparative proteomic analysis indicates differential responses to fumonisin B1 (FB1) and hydrolysed fumonisin B1 (HFB1) in IPEC-J2 porcine epithelial cells in vitro

  2025cites this paper
• Silencing of LncRNA XIST Suppressed Tumor Growth and Metastasis in Papillary Thyroid Carcinoma by Modulating miR-204/FN1 Axis

  2025cites this paper
• Study on the role of FN1 in chronic obstructive pulmonary disease.

  2025cites this paper
• Membranous Overexpression of Fibronectin Predicts Microvascular Invasion and Poor Survival Outcomes in Patients with Hepatocellular Carcinoma

  2025cites this paper
• The role of FN1 gene interference in neural differentiation of human bone marrow mesenchymal stem cells.

  2025cites this paper
• Gene Expression Profiles of AHNAK2, DCSTAMP, FN1, and TERT Correlate With Mutational Status and Recurrence in Papillary Thyroid Carcinoma

  2024cites this paper
• Transcription Factors and Markers Related to Epithelial–Mesenchymal Transition and Their Role in Resistance to Therapies in Head and Neck Cancers

  2024cites this paper
• Comparative profiling by data-independent acquisition mass spectrometry reveals featured plasma proteins in breast cancer: a pilot study

  2024cites this paper
• Investigation of mesenchymal stem cell secretome on breast cancer gene expression: A bioinformatic approach to identify differentially expressed genes, functional networks, and potential therapeutic targets

  2024cites this paper
• Unveiling 8,12‐Dimethoxysanguinarine: A Potent Inhibitor of Breast Cancer Metastasis via Fibronectin 1 Downregulation

  2024cites this paper
• 3D printed PGCL@PLA/10CSPL composite scaffolds loaded with fibronectin 1 for intervertebral disc degeneration treatment

  2024cites this paper
• Targeted Variant Assessments of Human Endogenous Retroviral Regions in Whole Genome Sequencing Data Reveal Retroviral Variants Associated with Papillary Thyroid Cancer

  2024cites this paper
• Exploring exosomes: novel diagnostic and therapeutic frontiers in thyroid cancer

  2024cites this paper
• Potential protein markers for differential diagnosis of thyroid neoplasms

  2024cites this paper
• Differentially expressed extracellular matrix genes functionally separate ameloblastoma from odontogenic keratocyst

  2024cites this paper
• Fibronectin contributes to a BRAF inhibitor-driven invasive phenotype in thyroid cancer through EGR1, which can be blocked by inhibition of ERK1/2.

  2023cites this paper
• NF-κB signaling activation and roles in thyroid cancers: implication of MAP3K14/NIK

  2023cites this paper
• Dual targeting of MAPK and PI3K pathways unlocks redifferentiation of Braf-mutated thyroid cancer organoids

  2023cites this paper
• The important role of miR-1-3p in cancers

  2023cites this paper
• Silencing the Long Non-coding RNA HOTAIR Inhibits Epithelial-Mesenchymal Transition in MKN45 Gastric Cancer Cell Line by Downregulation of Fibronectin-1 and Claudin-4

  2023cites this paper
• The impact of fibronectin knockout on invasion and migration of endometrial cell in adenomyosis

  2023cites this paper
• Proteomic Alteration in the Progression of Multiple Myeloma: A Comprehensive Review

  2023cites this paper
• MicroRNA-142-3P suppresses the progression of papillary thyroid carcinoma by targeting FN1 and inactivating FAK/ERK/PI3K signaling.

  2023cites this paper
• Shielding and nurturing: Fibronectin as a modulator of cancer drug resistance

  2023cites this paper
• Dual targeting of MAPK and PI3K pathways unlocks re-differentiation of Braf- 1 mutated thyroid cancer organoids

  2023cites this paper
• Proteomics profiling for the global and acetylated proteins of papillary thyroid cancers

  2023cites this paper
• The Role of Exosomes in Epithelial–to-Mesenchymal Transition and Cell Functional Properties in Head and Neck Cancer

  2023cites this paper
• Modeling Braf -induced thyroid cancer development and drug screening using 1 pluripotent stem cell-derived organoids 2

  2023cites this paper
• Eight Aging-Related Genes Prognostic Signature for Cervical Cancer

  2023cites this paper
• hsa_circ_0051428 Facilitates the Progression of Thyroid Cancer by Sponging miR-1248 to Up-Regulate FN1.

  2023cites this paper
• Expression of miR-31-5p affects growth, migration and invasiveness of papillary thyroid cancer cells

  2022cites this paper
• Single-Cell RNA Sequencing Revealed a 3-Gene Panel Predicted the Diagnosis and Prognosis of Thyroid Papillary Carcinoma and Associated With Tumor Immune Microenvironment

  2022cites this paper
• Identification of potential diagnostic and prognostic biomarkers for papillary thyroid microcarcinoma (PTMC) based on TMT-labeled LC–MS/MS and machine learning

  2022cites this paper
• FN1 promotes thyroid carcinoma cell proliferation and metastasis by activating the NF-κB pathway.

  2022cites this paper
• High Expression of Fibronectin 1 Predicts a Poor Prognosis in Glioblastoma

  2022cites this paper
• An integrative approach toward identification and analysis of therapeutic targets involved in HPV pathogenesis with a focus on carcinomas

  2022cites this paper
• The Autoantibodies against Tumor-Associated Antigens as Potential Blood-Based Biomarkers in Thyroid Neoplasia: Rationales, Opportunities and Challenges

  2022cites this paper
• Co-Encapsulation of Paclitaxel and JQ1 in Zein Nanoparticles as Potential Innovative Nanomedicine

  2022cites this paper
• Label-Free Proteome Pro ling for Lymphatic Metastasis in Papillary Thyroid Carcinoma

  2022cites this paper
• Identification of Candidate Therapeutic Target Genes and Profiling of Tumor-Infiltrating Immune Cells in Pancreatic Cancer via Integrated Transcriptomic Analysis

  2022cites this paper
• FN1 overexpression is correlated with unfavorable prognosis and immune infiltrates in breast cancer

  2022cites this paper
• Single-Cell Transcriptome Analysis Reveals Inter-Tumor Heterogeneity in Bilateral Papillary Thyroid Carcinoma

  2022cites this paper
• Increased Expression of FN1 in Head and Neck Squamous Cell Carcinoma Predicts Poor Prognosis

  2021cites this paper
• Lung cancer cell‐derived EDA‐containing fibronectin induces an inflammatory response from monocytes and promotes metastatic tumor microenvironment

  2021cites this paper
• Identification of Potential BRAF Inhibitor Joint Therapy Targets in PTC based on WGCAN and DCGA

  2021cites this paper
• Thyroid Carcinoma: Phenotypic Features, Underlying Biology and Potential Relevance for Targeting Therapy

  2021cites this paper
• Molecular alterations in oral cancer using high-throughput proteomic analysis of formalin-fixed paraffin-embedded tissue

  2021cites this paper
• Boosting GWAS using biological networks: A study on susceptibility to familial breast cancer

  2021cites this paper
• Weighted correlation network analysis identifies FN1, COL1A1 and SERPINE1 associated with the progression and prognosis of gastric cancer

  2021cites this paper
• Key drug-targeting genes in pancreatic ductal adenocarcinoma

  2021cites this paper
• Review of novel liquid-based biomarkers for prostate cancer: towards personalised and targeted medicine

  2021cites this paper
• Identification of the EMT-Related Genes Signature for Predicting Occurrence and Progression in Thyroid Cancer

  2021cites this paper
• DNA methylation association with stage progression of head and neck squamous cell carcinoma

  2021cites this paper
• A Five-Gene Prognostic Nomogram Predicting Disease-Free Survival of Differentiated Thyroid Cancer

  2021cites this paper
• Prognostic signatures associated with high infiltration of Tregs in bone metastatic prostate cancer

  2021cites this paper
• Over-Expression and Prognostic Significance of FN1, Correlating With Immune Infiltrates in Thyroid Cancer

  2021cites this paper
• The deubiquitinating enzyme ATXN3 promotes the progression of anaplastic thyroid carcinoma by stabilizing EIF5A2.

  2021cites this paper
• The Oncogene MYCN Modulates Glycolytic and Invasive Genes to Enhance Cell Viability and Migration in Human Retinoblastoma

  2021cites this paper
• Recurrence of Papillary Thyroid Cancer: A Systematic Appraisal of Risk Factors

  2021cites this paper
• OTT_A_301127 3119..3131

  2021cites this paper
• Review of novel tissue-based biomarkers for prostate cancer: towards personalised and targeted medicine

  2021cites this paper
• Overcoming resistance to BRAFV600E inhibition in melanoma by deciphering and targeting personalized protein network alterations

  2020cites this paper
• Biological networks and GWAS: comparing and combining network methods to understand the genetics of familial breast cancer susceptibility in the GENESIS study

  2020cites this paper
• Roles of Farnesyl-Diphosphate Farnesyltransferase 1 in Tumour and Tumour Microenvironments

  2020cites this paper
• Identi cation of Candidate Biomarkers Related to Diagnosis and Prognosis of Thyroid Cancer via Transcriptomic Pro le Analysis

  2020cites this paper
• Thyroid Cancer Prediction Using Gene Expression Profile, Pharmacogenomic Variants And Quantum Image Processing In Deep Learning Platform-A Theranostic Approach

  2020cites this paper
• Hsa_circ_0081534 increases the proliferation and invasion of nasopharyngeal carcinoma cells through regulating the miR-508-5p/FN1 axis

  2020cites this paper
• The anti-tumor effect of ursolic acid on papillary thyroid carcinoma via suppressing Fibronectin-1

  2020cites this paper
• IL‐34 is a potential biomarker for the treatment of papillary thyroid cancer

  2020cites this paper
• The Thyroid Tumor Microenvironment: Potential Targets for Therapeutic Intervention and Prognostication

  2020cites this paper
• Piperlongumine induces ROS mediated cell death and synergizes paclitaxel in human intestinal cancer cells.

  2020cites this paper
• Combining network-guided GWAS to discover susceptibility mechanisms for breast cancer

  2020cites this paper
• Circulating Tumor Cells and Fibronectin 1 in the Prognosis of Nasopharyngeal Carcinoma

  2020cites this paper
• Ranking cancer drivers via betweenness-based outlier detection and random walks

  2020cites this paper
• Oleacein inhibits STAT3, activates the apoptotic machinery, and exerts anti-metastatic effects in the SH-SY5Y human neuroblastoma cells.

  2020cites this paper
• Canine Thyroid Cancer: Molecular Characterization and Cell Line Growth in Nude Mice

  2020cites this paper
• Up-regulation of FN1, Activation of Maturation Promoting Factor and Associated Signaling Pathway Facilitates Epithelial-Mesenchymal Transition, Inhibits Apoptosis and Elevates Proliferation Rate of Breast Cancer Cells: In Silico Analysis of Microarray Datasets

  2020cites this paper
• Semi-synthetic product dihydroartemisinin inhibited fibronectin-1 and integrin-β1 and interfered with the migration of HCCLM6 cells via PI3K-AKT pathway

  2020cites this paper
• Identification of glutathione S-transferase π 1 as a prognostic proteomic biomarker for multiple myeloma using proteomic profiling

  2020cites this paper
• SRY-related HMG box-2 role in anaplastic thyroid cancer aggressiveness is related to the fibronectin 1 and PI3K/AKT pathway

  2020cites this paper
• CSN5 promotes carcinogenesis of thyroid carcinoma cells through ANGPTL2.

  2020cites this paper
• Signaling Complexity Measured by Shannon Entropy and Its Application in Personalized Medicine

  2019cites this paper
• BCL2 and hsa-miR-181a-5p are potential biomarkers associated with papillary thyroid cancer based on bioinformatics analysis

  2019cites this paper
• High expression of fibronectin 1 indicates poor prognosis in gastric cancer

  2019cites this paper
• Modifying the Tumour Microenvironment: Challenges and Future Perspectives for Anticancer Plasma Treatments

  2019cites this paper
• Quercetin improves the effects of sorafenib on growth and migration of thyroid cancer cells

  2019cites this paper
• Heterogenous nature of gene expression patterns in BRAF-like papillary thyroid carcinomas with BRAFV600E

  2019cites this paper
• Papillary Thyroid Carcinoma Variants are Characterized by Co-dysregulation of Immune and Cancer Associated Genes

  2019cites this paper
• Integrated Molecular Analysis of Papillary Renal Cell Carcinoma and Precursor Lesions Unfolds Evolutionary Process from Kidney Progenitor-Like Cells.

  2019cites this paper
• Epithelial-to-mesenchymal transition in thyroid cancer: a comprehensive review

  2019cites this paper
• Identification and analysis of genes associated with head and neck squamous cell carcinoma by integrated bioinformatics methods

  2019cites this paper
• MicroRNA-432 is downregulated in cervical cancer and directly targets FN1 to inhibit cell proliferation and invasion.

  2019cites this paper
• Constitutive Expression of NRAS with Q61R Driver Mutation Activates Processes of Epithelial–Mesenchymal Transition and Leads to Substantial Transcriptome Change of Nthy-ori 3–1 Thyroid Epithelial Cells

  2019cites this paper
• CREDO: Highly confident disease-relevant A-to-I RNA-editing discovery in breast cancer

  2019cites this paper
• Expression of Leptin Receptor and Effects of Leptin on Papillary Thyroid Carcinoma Cells

  2019cites this paper
• Identification and analysis of genes associated with papillary thyroid carcinoma by bioinformatics methods

  2019cites this paper
• Human telomerase reverse transcriptase in papillary thyroid cancer: gene expression, effects of silencing and regulation by BET inhibitors in thyroid cancer cells

  2019cites this paper